Renal Cell Cancer Update
Home About RCCU Other Tumor Types About us Contact Us
You are here: Home: RCCU 2 | 2008: Faculty Disclosures

CONTENT VALIDATION AND DISCLOSURES

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr FiglinConsulting Agreements: Biogen Idec, Idera Pharmaceuticals Inc, Keryx Biopharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Wyeth; Paid Research: Amgen Inc, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Pfizer Inc, Wyeth. Dr HudesAdvisory Committee: Centocor Ortho Biotech Services, Genentech BioOncology, GPC Biotech, Novartis Pharmaceuticals Corporation, Pfizer Inc; Speakers Bureau: Pfizer Inc. Dr BukowskiConsulting Agreements: Antigenics Inc, Bayer Pharmaceuticals Corporation, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Pfizer Inc, Roche Laboratories Inc, Wyeth.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.


This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

 

 

 

 

 

 

 

CME Test Online

Home

Editor
Neil Love, MD

Interviews

Robert A Figlin, MD
- Select publications

Gary R Hudes, MD
- Select publications

Ronald M Bukowski, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office

Media Center
Download PDF
Listen to audio files
Podcast
Previous issues
Terms of Use and General Disclaimer | Privacy Policy
Copyright © 2008 Research To Practice. All Rights Reserved.